Fig. 7
From: A novel serum protein biomarker for the late-stage diagnosis of nasopharyngeal carcinoma
Performance of FN1 in patients with different VCA-IgA or EBV DNA levels. A. Statistical significance of FN1 expression in the VCA-IgA-negative and -positive groups. B. ROC curve of FN1 in the VCA-IgA-negative groups. C. ROC curve of FN1 in the VCA-IgA-positive groups. D. Statistical significance of FN1 expression in EBV DNA-negative and -positive groups. E. ROC curve of FN1 in the EBV DNA-negative groups. F. ROC curve of FN1 in the EBV DNA-positive groups. G. Diagnostic power of FN1 in individuals who were misdiagnosed by VCA-IgA. H. Diagnostic power of FN1 in individuals who were misdiagnosed by EBV DNA. A, D. The centerline of each group represents the median value, and each dot represents a data point for an individual sample. The differences were analyzed by unpaired Student’s t test. G, H. The values in parentheses indicate the number of samples corresponding to each percentage. + , positive; − , negative; n, number of samples